Vertex Pharmaceuticals Stock Soars as Non-Opioid Pain Treatment Gets FDA Nod
Vertex Pharmaceuticals' newly FDA-approved non-opioid analgesic, Journavx, offers a groundbreaking alternative for managing acute pain.
BTC$60,312.00+2.08%
ETH$1,613.22+3.41%
USDT$0.9986+0.00%
USDC$0.99970.00%
XRP$1.06+1.91%
SOL$75.18+6.67%
TRX$0.3213-0.18%
FIGR_HELOC$1.05+2.60%
HYPE$66.74+9.75%
DOGE$0.0735+1.16%
RAIN$0.0159+2.62%
USDS$0.9996+0.01%
LEO$9.56+1.43%
ZEC$407.48+10.28%
XLM$0.1754+2.78%
BTC$60,312.00+2.08%
ETH$1,613.22+3.41%
USDT$0.9986+0.00%
USDC$0.99970.00%
XRP$1.06+1.91%
SOL$75.18+6.67%
TRX$0.3213-0.18%
FIGR_HELOC$1.05+2.60%
HYPE$66.74+9.75%
DOGE$0.0735+1.16%
RAIN$0.0159+2.62%
USDS$0.9996+0.01%
LEO$9.56+1.43%
ZEC$407.48+10.28%
XLM$0.1754+2.78%
Chevron Corporation's fourth-quarter earnings for 2024 showed improvement at $3.2 billion, or $1.84 per diluted share, despite significant charges for severance and impairments.
Vertex Pharmaceuticals' newly FDA-approved non-opioid analgesic, Journavx, offers a groundbreaking alternative for managing acute pain.
IBM's strong fourth-quarter results were driven by significant growth in its software division.
Caterpillar Inc.'s 4Q 2024 performance showcased a mixed bag, with a 5% decline in sales and revenues to $16.2 billion.
Cigna Group (NYSE: CI) reported its performance in the fourth quarter of 2024, with total revenues reaching $65.6 billion.
UPS (NYSE: UPS) reported revenues of $25.3 billion for the fourth-quarter of 2024, slightly below expectations.
T-Mobile's stellar performance in Q4 2024 showcased remarkable growth in customer numbers.
ADP reported a robust performance in the second quarter of fiscal 2025, with an 8% increase in revenues to $5.05 billion.
Boeing's fourth quarter financial results for 2024 fell below market expectations, with a reported GAAP loss per share of $5.46 and revenue of $15.2 billion.
Despite facing a challenging fourth quarter in 2024, General Motors managed to achieve an EBIT-adjusted of $2.5 billion.
SoFi Technologies, Inc. (NASDAQ: SOFI) reported a robust performance for the fourth quarter of 2024, with net revenue reaching $734.1 million.
AT&T's fourth-quarter results for 2024 exceeded market expectations with an adjusted EPS of $0.54 and revenues reaching $32.3 billion.
United Airlines' strategic reduction in domestic seat availability has boosted airline profitability by increasing ticket prices amid strong travel demand.